Bifidobacterium adolescentis IVS-1
Selected indexed studies
- Complete genome sequence of the probiotic Bifidobacterium adolescentis strain iVS-1. (Microbiol Resour Announc, 2023) [PMID:37943044]
- Two-week supplementation of Bifidobacterium adolescentis iVS-1 reduces symptoms associated with lactose intolerance in lactose maldigesters. (Gut Microbes Rep, 2025) [PMID:41909904]
- In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications. (Appl Environ Microbiol, 2015) [PMID:25616794]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. (2018) pubmed
- Complete genome sequence of the probiotic Bifidobacterium adolescentis strain iVS-1. (2023) pubmed
- Two-week supplementation of Bifidobacterium adolescentis iVS-1 reduces symptoms associated with lactose intolerance in lactose maldigesters. (2025) pubmed
- In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications. (2015) pubmed